STOCK TITAN

NextCure ends Beltsville lab lease, pays $0.8M

NextCure terminated its Beltsville, Maryland lease early, paying a one-time fee and forfeiting its security deposit to end future rent obligations.

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

NextCure, Inc. (NXTC) entered into a Ninth Amendment to its lease with ARE-8000/9000/10000 Virginia Manor, LLC covering approximately 29,864 rentable square feet of lab and office space in Beltsville, Maryland. The company vacated and surrendered the premises effective August 31, 2026, and the parties agreed to accelerate the lease expiration and terminate NextCure’s future rent obligations effective September 1, 2026, subject to the terms of the amendment.

In connection with this amendment, NextCure paid a one-time termination fee of approximately $0.8 million and forfeited a security deposit of approximately $39,000.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Rentable square feet terminated 29,864 square feet Remaining leased laboratory and office space at 8000 Virginia Manor Road, Beltsville, Maryland
Termination fee $0.8 million One-time payment in connection with the Ninth Amendment to the Beltsville lease
Security deposit forfeited $39,000 Security deposit forfeited as part of the lease termination arrangement
Vacate date August 31, 2026 Date NextCure vacated and surrendered the Beltsville premises
Lease termination effective date September 1, 2026 Date lease expiration and future rent obligations were accelerated and terminated
Material Definitive Agreement regulatory
"Item 1.01 Entry into a Material Definitive Agreement"
A material definitive agreement is a legally binding contract that creates major, long‑term obligations or rights for a company, such as loans, asset sales, mergers, or supplier deals. Think of it like a mortgage or lease for a business: it can change future cash flow, risk and control, so investors watch these agreements closely because they can materially affect a company’s value, financial health and stock price.
termination fee financial
"the Company paid a one-time termination fee of approximately $0.8 million"
A termination fee is a payment required if one party ends a contract before its agreed-upon end date. It acts like a penalty or compensation to the other party for canceling early, similar to a fee you might pay for breaking a lease or canceling a service contract. For investors, it matters because it can influence a company's decisions and financial obligations related to ending agreements prematurely.
security deposit financial
"forfeited its security deposit of approximately $39,000"
vacated and surrendered regulatory
"the Company vacated and surrendered the premises effective August 31, 2026"
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

FAQ

What lease change did NextCure (NXTC) disclose in this Form 8-K?

NextCure disclosed a Ninth Amendment to its lease for space at 8000 Virginia Manor Road, Beltsville, Maryland. The company vacated the approximately 29,864 rentable square feet of lab and office space and agreed to terminate future rent obligations effective September 1, 2026.

When did NextCure (NXTC) vacate the Beltsville premises and end rent obligations?

NextCure vacated and surrendered the Beltsville premises effective August 31, 2026. Under the Ninth Amendment, the expiration of the lease and the company’s future rent obligations were accelerated and terminated effective September 1, 2026, subject to the amendment’s terms.

How much did NextCure (NXTC) pay to terminate the Beltsville lease?

In connection with the lease amendment, NextCure paid a one-time termination fee of approximately $0.8 million. This payment was part of the agreement to accelerate the lease expiration and end its future rent obligations for the Beltsville facility.

What happened to NextCure’s security deposit under the lease amendment?

NextCure forfeited its security deposit of approximately $39,000 as part of the Ninth Amendment to the Beltsville lease. This forfeiture occurred in addition to the one-time termination fee paid to end the lease early.

How large was the Beltsville facility that NextCure (NXTC) vacated?

The Beltsville facility covered approximately 29,864 rentable square feet of leased laboratory and office space at 8000 Virginia Manor Road. This remaining space was subject to the Ninth Amendment under which the lease was terminated early.

Who was NextCure’s landlord under the terminated Beltsville lease?

The landlord under the amended Beltsville lease was ARE-8000/9000/10000 Virginia Manor, LLC. NextCure and this landlord entered into the Ninth Amendment to accelerate the lease expiration and terminate the company’s future rent obligations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
0001661059false00016610592026-09-032026-09-03

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 3, 2026

 

NextCure, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of incorporation)

 

001-38905
(Commission File Number)

 

47-5231247
(IRS Employer Identification No.)

 

 

2850 Quarry Lake Drive, Suite 280

Baltimore, Maryland

 

21209

(Address of principal

 

(Zip Code)

executive offices)

 

 

(240) 399-4900 

Registrant's telephone number, including area code:

8000 Virginia Manor Road, Suite 140

Beltsville, MD 20705

 (Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value per share

NXTC

Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

Item 1.01 Entry into a Material Definitive Agreement

On August 28, 2026, NextCure, Inc. (the "Company") and ARE-8000/9000/10000 Virginia Manor, LLC entered into a Ninth Amendment to the parties’ lease agreement dated January 30, 2019 (the "Amendment") with respect to the Company's remaining approximately 29,864 rentable square feet of leased laboratory and office space located at 8000 Virginia Manor Road, Beltsville, Maryland. Pursuant to the Amendment, the Company vacated and surrendered the premises effective August 31, 2026, and the parties agreed to accelerate the expiration of the lease and terminate the Company's future rent obligations effective September 1, 2026, subject to the terms of the Amendment.

In connection with the Amendment, the Company paid a one-time termination fee of approximately $0.8 million and forfeited its security deposit of approximately $39,000.

Item 9.01Financial Statements and Exhibits

(d) Exhibits

Exhibit No.

Description

10.1

Ninth Amendment to Lease Agreement, dated as of August 28, 2026, by and between the Company and ARE-8000/9000/10000 Virginia Manor, LLC

104

Cover Page Interactive Data File (formatted as inline XBRL)

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

November

Dated: September 3, 2026

NEXTCURE, INC.

 

 

 

 

By:

/s/ Steven P. Cobourn

 

Name:

Steven P. Cobourn

 

Title:

Chief Financial Officer

Filing Exhibits & Attachments

5 documents